Chemistry beyond the sequence

A new
dimension
of mRNA.

A programmable chemical control layer for mRNA. Built after synthesis. Designed around the performance you need.

mRNAAmptiv chemical modifications
Post-transcriptional RNA engineeringA different starting point
Our perspective

The sequence is the beginning.
Chemistry opens what comes next.

Conventional mRNA production limits the chemistry you can use. Amptiv adds chemical modifications after synthesis, opening new ways to engineer how an mRNA performs.

The Amptiv platform

One molecule.
More ways to shape its behavior.

We’re developing stable and reversible modifications to tune mRNA for the demands of different applications.

Engineer for the protein output you need.

Explore how added chemistry changes translation. Our goal is to match expression to the application, from a defined pulse to sustained protein production.

A different route to RNA design

Make the mRNA.
Then expand its possibilities.

Our chemistry starts where conventional design and synthesis stop, adding a new dimension to the RNA development workflow.

01 / SYNTHESIZE

Start with mRNA.

Produce the RNA using an established in vitro transcription workflow.

02 / MODIFY

Add new chemistry.

Introduce chemical groups after synthesis through Amptiv’s modification technology.

03 / EVALUATE

Measure what matters.

Evaluate molecular integrity and functional performance in the context of the intended application.

Introducing TailX™ / Early access

A small tail.A new opportunity.

Amptiv is now offering early access to TailX™, a new mRNA poly(A) tail modification kit. Evaluate longer-lasting expression in your own systems.

  • Longer expression duration, with increased post-peak AUC
  • Simple addition of chemical modifications to poly(A) tails
  • Integrated poly(A) enrichment and purification
AAAAAA POLY(A) TAILmRNA
About Amptiv

mRNA performance.
Designed for the medicine.

Amptiv chemically engineers mRNA after synthesis to tune expression, durability, stability, and immune response. We’re building a programmable control layer to help therapeutic developers match mRNA performance to the demands of each medicine.

Recognition & affiliations
Let’s build what comes next

What could your
mRNA do next?

Partner with Amptiv to engineer the expression, durability, and biological response your mRNA therapeutic needs.

Get in touch

Let’s talk RNA.

Tell us about your work and how we can help.

    Or email info@amptivbio.com directly.